Olema Pharmaceuticals (OLMA) Presents at 34th EORTC-NCI-AACR Symposium
Olema Pharmaceuticals(OLMA)2022-10-28 17:06| --- | --- | --- | |----------------------------------|-------|-------| | | | | | | | | | Phase 1/2 Study Update ENA 2022 | | | | October 26, 2022 | | | 1 Forward-Looking Statements 2 This presentation contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, stat ...